Alcaftadine is an H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Alcaftadine is the active ingredient of these drugs:
Brazil Ecuador Singapore United States
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):